{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pre-conception-advice-management/management/mental-health-problems/","result":{"pageContext":{"chapter":{"id":"7e7545d6-d6f7-57bc-89ea-6441a4ec2db1","slug":"mental-health-problems","fullItemName":"Scenario: Mental health problems","depth":2,"htmlHeader":"<!-- begin field 665e48ad-890a-407a-b872-d45b51b3564a --><h2>Scenario: Pre-conception advice - women with mental health problems</h2><!-- end field 665e48ad-890a-407a-b872-d45b51b3564a -->","summary":"Covers specific issues to be considered in a woman with a mental health problem who is planning a pregnancy.","htmlStringContent":"<!-- begin item dae7dbca-db7c-4771-8424-59ec22abf1b5 --><!-- begin field 661d0368-4171-401d-a802-acbd00863c7e --><p>From age 16 years to 45 years (Female).</p><!-- end field 661d0368-4171-401d-a802-acbd00863c7e --><!-- end item dae7dbca-db7c-4771-8424-59ec22abf1b5 -->","topic":{"id":"7fbac536-1f76-5678-a8d3-791cde12bdcc","topicId":"362122fc-a8d4-48c6-bbe1-260b84fdc035","topicName":"Pre-conception - advice and management","slug":"pre-conception-advice-management","lastRevised":"Last revised in November 2019","chapters":[{"id":"b4e662d9-e04d-5220-9289-f9d2f83a655d","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d516f1b7-0d03-56d1-a1ff-98ee4586d10c","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"05f2e291-0cb3-508a-a53a-203bf7452154","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"eea0164e-7605-53f2-82b1-30649c6b462b","slug":"changes","fullItemName":"Changes"},{"id":"3107f6a6-010e-5793-b49e-f188321b5d25","slug":"update","fullItemName":"Update"}]},{"id":"ccdc8c20-befb-5b1b-9e44-e7d66512c304","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d2c77d6a-aa8b-5f5a-bc22-e802a1ed63dd","slug":"goals","fullItemName":"Goals"},{"id":"354ac657-195c-55c7-86dc-32bd495719e6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"90c0a8b7-d685-5b54-ab19-50262a840059","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8991e1d6-fe99-54e2-a7f0-8c087cbc913e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ce6a54cd-7770-5f7d-b3d4-72d82e13e288","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"cea8adf5-cc1a-59e9-b1bc-a7fe7dd9612e","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8ebfaff6-f12e-5e6d-a4da-824f9755cc22","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"eb257b56-0f26-5b88-b016-779a5c57372a","slug":"definition","fullItemName":"Definition"}]},{"id":"cb07c890-793e-585a-b84c-853632ed27ce","fullItemName":"Management","slug":"management","subChapters":[{"id":"bd42d278-6050-5b5b-866a-cbfbf0423199","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"eb9c8dbd-e2aa-5e1d-ad75-0f16e58a1422","slug":"advice-for-all-women","fullItemName":"Scenario: Advice for all women"},{"id":"7e7545d6-d6f7-57bc-89ea-6441a4ec2db1","slug":"mental-health-problems","fullItemName":"Scenario: Mental health problems"},{"id":"1a2f1279-2d58-50c7-9319-7566398adf95","slug":"chronic-medical-conditions","fullItemName":"Scenario: Chronic medical conditions"},{"id":"06434a48-ae53-5381-a6e0-d1d478bf119e","slug":"genetic-risk-assessment","fullItemName":"Scenario: Genetic risk assessment"}]},{"id":"09ba2cc8-ed92-569e-8221-2fc8961a9165","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5d207bb7-2d21-5faf-8689-655bc58b847f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5c10ffbd-047a-5920-9dc4-cfc597cebbad","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aaed13a3-4796-527d-97c1-0d3f0522735c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d4f44dbc-1899-520a-af01-19a4c31b4859","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"78c00268-d8ca-507c-b64e-d937902ec290","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8a776444-784a-5839-9597-61faaeeb2101","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6a3cee62-2ded-5f48-b3fc-9b11a7a28a12","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cb07c890-793e-585a-b84c-853632ed27ce","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1a377609-1466-59f5-85ce-ccb1d4cd4f74","slug":"mental-health-problems","fullItemName":"Mental health problems","depth":3,"htmlHeader":"<!-- begin field d5f3cf00-40d6-4fa1-bbe5-a7ba00d32be6 --><h3>How should I manage a woman with a mental health problem who wants to become pregnant?</h3><!-- end field d5f3cf00-40d6-4fa1-bbe5-a7ba00d32be6 -->","summary":null,"htmlStringContent":"<!-- begin item cb2d18d8-ef0f-4d06-b918-a7ba00d31cf5 --><!-- begin field a3bd88f3-5d67-492d-bae0-a7ba00d32be6 --><ul><li><strong>Discuss with the woman:</strong><ul><li>How pregnancy and childbirth could affect her mental health problem (for example risk of relapse). </li><li>How her mental health problem and/or its treatment might affect her or her baby, before and after birth. </li><li>The risks of not treating her condition and the importance of controlling symptoms before conception.</li></ul></li><li><strong>Consider referring women with a current or past severe mental health problem</strong> (for example severe depressive disorders, bipolar disorder, and psychosis) to secondary care for pre-conception counselling. Ideally refer to a specialist perinatal mental health service, if available. <ul><li>Advise the woman to continue using effective contraception until a full assessment by the psychiatrist has taken place.</li><li>Advise the woman not to stop taking her medication unless otherwise directed by the psychiatrist.</li><li>For more information on the pre-conception care of women with bipolar disorder and psychosis and schizophrenia, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/bipolar-disorder/\">Bipolar disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/psychosis-schizophrenia/\">Psychosis and schizophrenia</a>.</li></ul></li><li><strong>Manage women who do not require referral, </strong>using clinical judgement and taking into account the woman's past history, and her preferences. <ul><li>Treatment options include continuing the woman's current drug regime, switching to a regime with a lower risk of adverse effects, or stopping treatment (avoid abrupt discontinuation of medication). <ul><li>Advise the woman not to stop taking her medication unless otherwise directed by a clinical specialist in mental health. </li></ul></li><li>Discuss the potential benefits of psychological interventions and psychotropic medication, the consequences of altering or stopping treatment, and potential harms of treatment<strong>.</strong></li><li>When prescribing psychotropic medication for women planning a pregnancy, consider the latest data on risks to the fetus and baby.<ul><li>The UK Teratology Information Service provides detailed information on the safety of medicines in pregnancy, available at <a href=\"http://www.uktis.org/\" data-hyperlink-id=\"c333dcee-ecf3-4613-acf0-a93100a7cc19\">www.uktis.org</a>.</li><li>For more information on the use of antidepressant drugs in pregnancy, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/depression-antenatal-postnatal/\">Depression - antenatal and postnatal</a>. </li></ul></li><li>Seek specialist advice if in doubt about the risks of the mental health problem or the benefits and harms of treatment in pregnancy, preferably from a specialist perinatal mental health service.</li></ul></li><li>Measure prolactin levels in women planning a pregnancy who are taking prolactin-raising antipsychotic medication. </li><li>Offer written patient information, such as that available from the Royal College of Psychiatrists on <a href=\"http://www.rcpsych.ac.uk/healthadvice/treatmentswellbeing/planningapregnancy.aspx\" data-hyperlink-id=\"bd66ef72-3e99-4948-8435-a93100a7cc85\">Planning a pregnancy</a> at <a href=\"http://www.rcpsych.ac.uk/\" data-hyperlink-id=\"a35795f2-ad2e-4885-bb1c-a93100a7ccf1\">www.rcpsych.ac.uk</a>. The UK Teratology Information Service has produced a selection of patient information leaflets — best use of medicines in pregnancy (bumps), available at <a href=\"http://www.medicinesinpregnancy.org/\" data-hyperlink-id=\"2a4e16b9-31fb-4d4f-b27e-a93100a7cd9f\">www.medicinesinpregnancy.org</a>.</li><li>Offer general pre-pregnancy advice (see <a class=\"topic-reference internal-reference\" href=\"/topics/pre-conception-advice-management/management/advice-for-all-women/\">Advice for all women</a>).</li></ul><!-- end field a3bd88f3-5d67-492d-bae0-a7ba00d32be6 --><!-- end item cb2d18d8-ef0f-4d06-b918-a7ba00d31cf5 -->","subChapters":[{"id":"8e3f7b28-547c-577f-bb39-2dfbb3d5b436","slug":"basis-for-recommendation-d9d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8dead477-89a1-41fd-91f0-a7ba00d32c80 --><h4>Basis for recommendation</h4><!-- end field 8dead477-89a1-41fd-91f0-a7ba00d32c80 -->","summary":null,"htmlStringContent":"<!-- begin item d9d7b5e6-fe5c-4a3a-8265-a7ba00d32c80 --><!-- begin field fab4ff74-d155-463d-aa6e-a7ba00d32cc7 --><h5>Discussion of the woman's mental health problem and the impact of pregnancy and childbirth.</h5><ul><li>This recommendation is based on the National Institute for Health and Care Excellence (NICE) guideline <em>Antenatal and postnatal mental health: clinical management and service guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2014</a>]<strong> </strong>and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Callegari et al, 2015</a>]. </li></ul><h5>Referral of women with a current or past severe mental health problem who are planning a pregnancy</h5><ul><li>This recommendation is based on the NICE guideline <em>Antenatal and postnatal mental health: clinical management and service guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2014</a>]<strong> </strong>and a British Association of Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">McAllister-Williams et al, 2017</a>].<ul><li>Optimal management of a woman's mental health problem during pregnancy is important because there is an association between psychiatric disorders in pregnancy and adverse obstetric and infant outcomes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">Lassi et al, 2014</a>].<strong> </strong>A position paper from the American Academy of Family Physicians on <em>Preconception care</em> is of the opinion that achieving control of depression and anxiety disorders before conception can help prevent negative outcomes for a woman and her family [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">AAFP, 2015</a>]. </li><li>Pre-conception advice is important when the woman's current medication is associated with risk of teratogenicity (for example anticonvulsant mood stabilisers such as valproate or carbamazepine) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">McAllister-Williams et al, 2017</a>]. Because of the risks of some drugs to a pregnancy, CKS recommends continuing effective contraception until a woman planning a pregnancy has been seen by a specialist. Even if the decision is made to discontinue treatment, for some drugs effective contraception may need to be continued for a period of time, depending on the half-life and teratogenicity of the drug [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">McAllister-Williams et al, 2017</a>]. </li><li>CKS advises not stopping medication unless otherwise directed by the psychiatrist because if the illness is untreated there may be an increased risk of relapse which can cause adverse effects for the woman and her pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">McAllister-Williams et al, 2017</a>]<strong> </strong></li></ul></li></ul><h5>Management of women who do not require referral</h5><ul><li>These recommendations are pragmatic and take into account recommendations in the NICE guideline <em>Antenatal and postnatal mental health: clinical management and service guidance</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2014</a>]<strong> </strong>and a British Association of Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">McAllister-Williams et al, 2017</a>].<strong> </strong></li></ul><h5>Measurement of prolactin levels</h5><ul><li>This recommendation is based on the NICE guideline <em>Antenatal and postnatal mental health: clinical management and service guidance. </em>Testing is advised because increased levels of prolactin can reduce a woman's chance of becoming pregnant [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pre-conception-advice-management/references/\">NICE, 2014</a>].</li></ul><h5>Offering written patient information</h5><ul><li>This recommendation is pragmatic and is based on what CKS considers to be good clinical practice.</li></ul><!-- end field fab4ff74-d155-463d-aa6e-a7ba00d32cc7 --><!-- end item d9d7b5e6-fe5c-4a3a-8265-a7ba00d32c80 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}